Study of AC-201 in Patients With Type 2 Diabetes Mellitus

Update Il y a 4 ans
Reference: NCT01276106

Woman and Man

Extract

This is a 24-week randomized placebo-controlled study to investigate the effect of an oral IL-1beta inhibitor AC-201 in patients with type 2 diabetes mellitus already treated on different background diabetes therapies.


Inclusion criteria

  • Type 2 diabetes mellitus

Links